June 27, 2025 3:24 pm
Published by Julia Shanu-Wilson
Paper Pick – Intestinal Secretion Is a Potentially Important Clearance Mechanism for Low Metabolic Clearance Compounds In this paper, scientists...
View Article
June 6, 2025 12:44 pm
Published by Julia Shanu-Wilson
Biocatalytic paths to the synthesis of selected metabolites of Iptacopan In a recent paper published in celebration of the 20th...
View Article
May 7, 2025 6:33 pm
Published by Julia Shanu-Wilson
Small but mighty: the impact of tertiary alcohols in drug design By Julia Shanu-Wilson Creating a drug with perfect drug-like...
View Article
March 13, 2025 10:02 am
Published by Julia Shanu-Wilson
Launch of PolyUGTs Kits Our PolyUGTs screening and scale-up kits are now available! They’re a super easy way to make...
View Article
February 20, 2025 5:41 pm
Published by Julia Shanu-Wilson
Oxidative biotransformation of elinzanetant to 3 active metabolites Elinzanetant is a dual neurokinin-1,3 receptor antagonist under development for treatment of...
View Article
February 20, 2025 9:02 am
Published by Julia Shanu-Wilson
Welcome to Matt and Xianfu We are delighted that Matthew Allen and Xianfu Li have joined Hypha’s team recently. Xianfu was previously at...
View Article
February 7, 2025 3:35 pm
Published by Julia Shanu-Wilson
CYP3A-Mediated Metabolism of Suzetrigine By Julia Shanu-Wilson It’s been more than 20 years since a pain drug with a new...
View Article
January 22, 2025 2:34 pm
Published by Julia Shanu-Wilson
Metabolism of 2024 FDA approved small molecules part 1 By Julia Shanu-Wilson Involvement of active metabolites The number of small...
View Article
December 12, 2024 5:34 pm
Published by Julia Shanu-Wilson
The Current State of Biotransformation Science Industry Survey of In Vitro and In Vivo Practices, Clinical Translation, and Future Trends...
View Article
December 11, 2024 11:13 am
Published by Julia Shanu-Wilson
Hypha’s Q4 2024 Newsletter – Accessing glucuronides, a new UGT kit and our latest paper picks and blog article Focus topics...
View Article